论文部分内容阅读
通过对594例肝胆疾病患者的 AFP 动态观察,证明各种肝胆疾病时血清的 AFP 均不同程度升高,但各有其规律。除肝癌外其余疾病的 AFP 随病程进展和治疗显示下降趋势。研究表明,AFP 升高并非肝癌特异性指标,但肝癌时 AFP 含量高、增速猛、不易下降,有相对稳定性和在较高浓度呈持续波动。
Through the dynamic observation of AFP in 594 patients with hepatobiliary disease, serum AFP in various liver and gallbladder diseases were increased to different degrees, but each had its own laws. In addition to liver cancer other diseases AFP with the course of disease progression and treatment showed a downward trend. Studies have shown that elevated AFP is not a specific indicator of liver cancer, but liver cancer AFP content is high, fierce growth, not easy to decline, the relative stability and continued fluctuations in higher concentrations.